Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%
- Check24 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update aSummaryDifference0.1%
- Check38 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element; no core content, pricing, stock, or time-related information changed.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.1%
- Check53 days agoChange DetectedThe web page has been updated to include new facility and publication information related to prostate cancer research, while several previous location and genetic resource details have been removed.SummaryDifference5%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.